Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Amid rising debate within the medical community, the US FDA has spoken out to defend how it reviews and authorizes new ...

Venture capitalists Patrick Heron of Frazier Healthcare Partners, Michael Gladstone of Atlas Venture and Paulina Hill of Polaris Partners join WSJ Pro to explain how biotech startups get off the ...

Insilico recently announced the pilot launch of its Automated AI-Driven Partnering System. This first of its kind business development automation ...

Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last ...

The US Food and Drug Administration (FDA) has fast-tracked a promising new gene therapy, KB707, which is inhaled as a fine mist for the targeted treatment of advanced or metastatic non-small-cell lung ...

It is nearly eight years since healthcare and biotech investor Sam Isaly abruptly stepped down from OrbiMed, the managers of the Worldwide Healthcare Trust (LSE: WWH). In the 22 years in which he was ...

Researchers at the Tianjin Institute of Industrial Biotechnology have reportedly found a way to synthesize starch directly from carbon dioxide. Achieved using only enzymes and raw materials, this new ...

Biotech valuations are lower relative to other sectors after a decade of stagnation. Denali Therapeutics fell 75% over five years despite its patented blood-brain barrier transport platform. Xenon ...

China is pumping money into its biotech industry, helping launch a new wave of labs and incubators in the country. Experts say this could slow down American innovation in the biotech space. China's ...

2025 proved a turning point year for the biotech industry, albeit one wrought with contradiction. The post-COVID slump experienced by the industry seemed due to continue, with the sweeping cuts to the ...

Biotech IPOs hit lowest level in over a decade in 2025 Investors focus on biotechs with mature pipelines and positive trial data Lower interest rates and capital inflows expected to boost sector Jan ...